Literature DB >> 20658946

A high-throughput screen for alpha particle radiation protectants.

Jonathan H Seideman1, David Shum, Hakim Djaballah, David A Scheinberg.   

Abstract

Alpha-particle-emitting elements are of increasing importance as environmental and occupational carcinogens, toxic components of radiation dispersal devices and accidents, and potent therapeutics in oncology. Alpha particle radiation differs from radiations of lower linear energy transfer in that it predominantly damages DNA via direct action. Because of this, radical scavengers effective for other radiations have had only limited effect in mitigating alpha particle toxicity. We describe here a simple assay and a pilot screen of 3,119 compounds in a high-throughput screen (HTS), using the alpha-particle-emitting isotope, ²²⁵Ac, for the discovery of compounds that might protect mammalian cells from alpha particles through novel mechanisms. The assay, which monitored the viability of a myeloid leukemic cell line upon alpha particle exposure, was robust and reproducible, yielding a Z' factor of 0.66 and a signal-to-noise ratio of nearly 10 to 1. Surprisingly, 1 compound emerged from this screen, epoxy-4,5-α-dihydroxysantonin (EDHS), that showed considerable protective activity. While the value of EDHS remains to be determined, its discovery is a proof of concept and validation of the utility of this HTS methodology. Further application of the described assay could yield compounds useful in minimizing the toxicity and carcinogenesis associated with alpha particle exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658946      PMCID: PMC2978061          DOI: 10.1089/adt.2010.0291

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  32 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Development of realistic RDD scenarios and their radiological consequence analyses.

Authors:  Hyeongki Shin; Juyoul Kim
Journal:  Appl Radiat Isot       Date:  2009-02-20       Impact factor: 1.513

Review 3.  Radioimmunotherapy with alpha-emitting nuclides.

Authors:  M R McDevitt; G Sgouros; R D Finn; J L Humm; J G Jurcic; S M Larson; D A Scheinberg
Journal:  Eur J Nucl Med       Date:  1998-09

4.  Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells.

Authors:  S Johansson; P Lindholm; J Gullbo; R Larsson; L Bohlin; P Claeson
Journal:  Anticancer Drugs       Date:  2001-06       Impact factor: 2.248

5.  Radon and lung cancer: the BEIR IV Report.

Authors:  J I Fabrikant
Journal:  Health Phys       Date:  1990-07       Impact factor: 1.316

6.  Lead-induced cytotoxicity and transcriptional activation of stress genes in human liver carcinoma (HepG2) cells.

Authors:  Paul B Tchounwou; Clement G Yedjou; Dominique N Foxx; Ali B Ishaque; Elaine Shen
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein.

Authors:  T McGrath; M S Center
Journal:  Biochem Biophys Res Commun       Date:  1987-06-30       Impact factor: 3.575

8.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  A cohort study in southern China of tin miners exposed to radon and radon decay products.

Authors:  X Z Xuan; J H Lubin; J Y Li; L F Yang; A S Luo; Y Lan; J Z Wang; W J Blot
Journal:  Health Phys       Date:  1993-02       Impact factor: 1.316

10.  Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.

Authors:  Håkan Andersson; Elin Cederkrantz; Tom Bäck; Chaitanya Divgi; Jörgen Elgqvist; Jakob Himmelman; György Horvath; Lars Jacobsson; Holger Jensen; Sture Lindegren; Stig Palm; Ragnar Hultborn
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

View more
  7 in total

1.  Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.

Authors:  Thapi D Rao; Nestor Rosales; David R Spriggs
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

2.  A high-throughput scintillation proximity-based assay for human DNA ligase IV.

Authors:  Hui-Min Tseng; David Shum; Bhavneet Bhinder; Sindy Escobar; Nicholas J Veomett; Alan E Tomkinson; David Y Gin; Hakim Djaballah; David A Scheinberg
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

3.  An image-based biosensor assay strategy to screen for modulators of the microRNA 21 biogenesis pathway.

Authors:  David Shum; Bhavneet Bhinder; Constantin Radu; Thalia Farazi; Markus Landthaler; Thomas Tuschl; Paul Calder; Christina N Ramirez; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2012-08       Impact factor: 1.339

4.  A high throughput scintillation proximity imaging assay for protein methyltransferases.

Authors:  Glorymar Ibanez; David Shum; Gil Blum; Bhavneet Bhinder; Constantin Radu; Christophe Antczak; Minkui Luo; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2012-06-01       Impact factor: 1.339

5.  A novel high throughput 1536-well Notch1 γ -secretase AlphaLISA assay.

Authors:  De-Ming Chau; David Shum; Constantin Radu; Bhavneet Bhinder; David Gin; M Lane Gilchrist; Hakim Djaballah; Yue-Ming Li
Journal:  Comb Chem High Throughput Screen       Date:  2013-07       Impact factor: 1.339

6.  A class of allosteric caspase inhibitors identified by high-throughput screening.

Authors:  Taya Feldman; Venkataraman Kabaleeswaran; Se Bok Jang; Christophe Antczak; Hakim Djaballah; Hao Wu; Xuejun Jiang
Journal:  Mol Cell       Date:  2012-07-12       Impact factor: 17.970

7.  Resazurin-based assay for screening bacteria for radiation sensitivity.

Authors:  Deborah A Hudman; Neil J Sargentini
Journal:  Springerplus       Date:  2013-02-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.